ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo

Gene Therapy

Volumn 4, Issue 10, 1997, Pages 1100-1106

  Ferrari, S ^a   Moro, E ^a   Pettenazzo, A ^a   Behr, J P ^b   Zacchello, F ^a   Scarpa, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cystic fibrosis; Gene therapy; Lung; Synthetic vectors

Indexed keywords

AZIRIDINE DERIVATIVE; LUCIFERASE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HISTOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPORTER GENE; TRANSGENE;

ADENOVIRIDAE; ANIMALIA; BRONCHUS; ORYCTOLAGUS CUNICULUS;

EID: 0030729180     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300503     Document Type: Article

References (27)

1. Rommens JM et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
2. Riordan JR et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
3. Zabner J et al. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 1996; 97: 1504-1511.
4. Fisher KJ et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217: 11-22.
5. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1995; 1: 39-46.
6. Sorscher EJ et al. Clinical protocol. Gene therapy for cystic fibrosis using cationic liposome-mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway. Hum Gen Ther 1994; 5: 1259-1277.
7. Yoshimura K et al. Expression of the human cystic fibrosis trans-membrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res 1992; 20: 3233-3240.
8. Logan JJ et al. Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium. Gene Therapy 1995; 2: 38-49.
9. Zhu N, Liggit D, Lui Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-211.
10. Hyde SC et al. Correction of ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993; 362: 250-255.
11. McLachlan G et al. Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy Gene Therapy 1995; 2: 614-622.
12. Behr JP, Demeneix B, Loeffler JP, Ferez MJ. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA 1989; 86: 6982-6986.
13. Fortunati E et al. In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes. Biochim Biophys Acta 1996; 1306: 55-62.
14. Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
15. Abdallah B et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gen Ther 1996; 7: 1947-1954.
16. Gruenert DC et al. Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci USA 1988; 85: 5951-5955.
17. Cozens AL et al. Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci USA 1992; 89: 5171-5175.
18. Behr JP. Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. Bioconj Chem 1994; 5: 382-389.
19. Remy JS et al. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci USA 1995; 92: 1744-1748.
20. Behr JP. L'éponge à protons: un moyen d'entrer dans une cellule auquel les virus n'ont pas pensé. Médecine/Sciences 1996; 12: 56-59.
21. Schwartz B et al. Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio. Hum Gen Ther 1995; 6: 1515-1524.
22. Plank C, Mechtler K, Szoka FC, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gen Ther 1996; 7: 1437-1446.
23. Meyer KB et al. Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics. Gene Therapy 1995; 2: 450-460.
24. Sawa T et al. Intraluminal water increases expression of plasmid DNA in rat lung. Hum Gene Ther 1996; 7: 933-941.
25. MacGregor GR, Caskey CT. Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res 1989; 17: 2365.
26. de Wet JR et al. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 1987; 7: 725-737.
27. Barthel F, Remy JS, Loeffler JP, Behr JP. Gene transfer optimization with lipospermine-coated DNA. DNA Cell Biol 1993; 12: 553-560.